Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Photoreceptors and Visual Pathways

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Digital monitoring of disease activity in relapsing-remitting multiple sclerosis.

Journal of neurology·2026

Same author

Promising patient experiences with a smartphone app and remote coaching for improving physical activity and protein intake to enhance recovery after oncological surgery: a multi-methods study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025

Same author

Associations between physical fitness and structural and functional MRI measures in secondary progressive multiple sclerosis: Cross-sectional findings from the exercise PRO-MS study.

Multiple sclerosis and related disorders·2025

Same author

The relation between cognitive-behavioural responses to symptoms in patients with long term medical conditions and the outcome of cognitive behavioural therapy for fatigue - A secondary analysis of four RCTs.

Behaviour research and therapy·2022

Same author

COVID-19 reinfection after pregnancy.

Infectious diseases now·2022

Same author

Self-regulation as rehabilitation outcome: what is important according to former patients?

Disability and rehabilitation·2021

Search research articles

Related Experiment Video

Updated: Jul 16, 2026

Modeling Cataract Surgery in Mice

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

[Secondary cataract: a problem resolved].

M J Tassignone¹, L Gobin, I Leysen

¹Oogheelkunde, Universitair Ziekenhuis Antwerpen, Edegem.

Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique

|February 20, 2007

Summary

A novel intraocular lens (IOL) prevents posterior capsule opacification (PCO) after cataract surgery by capturing lens epithelial cells (LECs). This innovative IOL design achieved 0% PCO and excellent outcomes, even in pediatric patients.

More Related Videos

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Related Experiment Videos

Last Updated: Jul 16, 2026

Modeling Cataract Surgery in Mice

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Area of Science:

Ophthalmology
Biomedical Engineering
Surgical Innovation

Context:

Posterior capsule opacification (PCO) is the most frequent complication following cataract surgery.
Existing intraocular lens (IOL) designs do not actively prevent PCO.
Lens epithelial cell (LEC) proliferation is the primary cause of PCO.

Purpose:

To introduce a novel intraocular lens (IOL) designed to eradicate posterior capsule opacification (PCO).
To describe the mechanism by which the IOL haptics capture residual lens epithelial cells (LECs).
To evaluate the safety, efficacy, and refractive outcomes of this PCO-preventing IOL.

Summary:

A new IOL features specialized haptics designed to trap LECs in a confined capsular equator area, inhibiting their proliferation.
Surgical techniques and devices were developed to facilitate the implantation of this IOL.
The study demonstrated the technique's safety, showing minimal postoperative inflammation and a low complication rate.
Excellent refractive results were achieved, with a notable 0% incidence of PCO in all patient groups.

Impact:

This IOL technology offers a potential solution to eliminate PCO, a major cause of visual impairment post-cataract surgery.
The 0% PCO rate, particularly in pediatric cases, suggests significant potential for improved long-term visual function and reduced need for corrective lenses.
The findings support the clinical utility of this IOL for achieving superior visual outcomes and patient satisfaction.